Optomed

1.54 EUR

-1.41%

5,661 following
Corporate customer

OPTOMED

NASDAQ Helsinki

Medical Equipment & Services

Health Care

-1.41 %
-32.96 %
-60.16 %
-59.10 %
-62.39 %
-61.97 %
-62.30 %
-86.23 %
-66.33 %

Optomed operates in the medical technology sector. The company conducts research and development of specialized eye cameras. Development takes place of both hardware and software that are resold under different brands. Operations are held on a global level, with the largest presence in the Nordic market. Customers consist of research institutes and hospitals. The company has its headquarters in Oulu.

Read more
Market cap
33.08M EUR
Turnover
347.6K EUR
P/E (adj.) (26e)
-11.41
EV/EBIT (adj.) (26e)
-8.45
P/B (26e)
1.56
EV/S (26e)
1.59
Dividend yield-% (26e)
-
Coverage
Recommendation
Accumulate
Target price
2.00 EUR
Updated
07.05.2026
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
14.8
2026

Interim report Q2'26

6.11
2026

Interim report Q3'26

Risk
Business risk
Valuation risk
Low
High

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Optomed Q4'25 preview: Fokus på forventninger
Analyst Comment by

Optomed Q4'25 preview: Fokus på forventninger

Optomed offentliggør sit Q4 regnskab næste tirsdag. Hovedfokus i regnskabet er rettet mod omsætningsvækstprognosen for 2026, som vi forventer vil være i form af "stærk vækst". Vores opmærksomhed i regnskabsmeddelelsen er især rettet mod den kommercielle udvikling af vækstfaktorerne i Udstyr-segmentet, såsom Aurora AEYE-løsningen og Optomed Lumo.

Forum discussions
There is nothing wrong with LinkedIn or other social media posts. Quite the opposite. They provide good background information both on a general level and more specific, important info. For example, that Gitex Africa event post you shared contained significant information for shareholders...
LinkedIn #optomedlumo #optomedaurora #portable #retinal #screening #ai #capturinghealth... World Congress of Diabetes Technology & Therapeutics 2026 - Mumbai India Taking the next steps within our strategy in India and approaching diabetes communities and experts with #OptomedLumo...
LinkedIn The Remidio retinal scanner shows how even the smallest innovations can have... The Remidio retinal scanner shows how even the smallest innovations can have an outsized impact on maternal care. It’s a portable, battery-operated camera that captures high-resolution images...
There are several of these camera manufacturers: Topcon, Canon, Nidek, Zeiss, iCare… They are used when high-volume imaging is required.
There is a fundamental problem with this entire setup: the camera at the core of everything is simply not good enough. The camera has been on the market for over 15 years, yet it still hasn’t made a proper breakthrough. Yes, the camera has been developed and new versions have been...
If the FDA and CE-approved Remidio handheld camera were “bad,” Bill Gates wouldn’t be holding it. It can be as bulky as it wants as long as it does its job and is accepted by the market.
What a clumsy-looking hunk of junk. And it doesn’t have FDA clearance for AI scans. Juho mentioned at the annual general meeting that Lumo might potentially have a lighter approval process since Aurora already has FDA clearance, so the number of required images and studies could ...
Read more on our forum